-
From the Editor-in-Chief
COVID-19 and Cancer in 2022
Is it the beginning of the end or the end of the beginning?
by William G. Nelson, MD, PhD
-
Policy Matters
Patient Advocacy Is Driving Change
Patient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.
by Carrie Treadwell, MBA
-
Understanding Stress and Cancer
A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
-
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
-
Making Collaboration More Common for Rare Cancers
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Medicaid: A Partial Safety Net
Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.
by Sharon Tregaskis
-
Forward Look
Adequate Representation
Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Policy Matters
Cancer Research: The Key to Tomorrow’s Cures
The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.
by David A. Tuveson, MD, PhD
-
Get Involved
Doing Yoga in Recovery
A volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Facts and Stats
Fifty Years of Growing Survivorship
More people in the U.S. are alive after being diagnosed with cancer than ever before.
by Eric Fitzsimmons
Cancer Talk
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
Childhood Cancer Survivors Face Higher Mortality for DecadesAn increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.
by Sandra Gordon
From the AACR
-
The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Research in cancer interception aims to characterize tumors at the earliest stages of development.
-
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Dr. Patricia LoRusso’s parents both died of cancer when she was a teenager, inspiring her to become an oncologist and develop new treatments for people with cancer.
Video
Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR
